ES543997A0 - Un procedimiento para la preparacion de derivados de 1,4-dihidropiridina. - Google Patents

Un procedimiento para la preparacion de derivados de 1,4-dihidropiridina.

Info

Publication number
ES543997A0
ES543997A0 ES543997A ES543997A ES543997A0 ES 543997 A0 ES543997 A0 ES 543997A0 ES 543997 A ES543997 A ES 543997A ES 543997 A ES543997 A ES 543997A ES 543997 A0 ES543997 A0 ES 543997A0
Authority
ES
Spain
Prior art keywords
procedure
preparation
dihydropyridine derivatives
dihydropyridine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES543997A
Other languages
English (en)
Other versions
ES8704480A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp
Pfizer Inc
Original Assignee
Pfizer Corp
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp, Pfizer Inc filed Critical Pfizer Corp
Publication of ES8704480A1 publication Critical patent/ES8704480A1/es
Publication of ES543997A0 publication Critical patent/ES543997A0/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ES543997A 1984-06-07 1985-06-07 Un procedimiento para la preparacion de derivados de 1,4-dihidropiridina. Expired ES8704480A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848414518A GB8414518D0 (en) 1984-06-07 1984-06-07 Therapeutic agents

Publications (2)

Publication Number Publication Date
ES8704480A1 ES8704480A1 (es) 1987-04-01
ES543997A0 true ES543997A0 (es) 1987-04-01

Family

ID=10562060

Family Applications (1)

Application Number Title Priority Date Filing Date
ES543997A Expired ES8704480A1 (es) 1984-06-07 1985-06-07 Un procedimiento para la preparacion de derivados de 1,4-dihidropiridina.

Country Status (14)

Country Link
US (1) US4647565A (es)
EP (1) EP0168151A1 (es)
JP (1) JPS6133185A (es)
KR (1) KR860000286A (es)
AU (1) AU554571B2 (es)
DK (1) DK253585A (es)
ES (1) ES8704480A1 (es)
FI (1) FI852221L (es)
GB (1) GB8414518D0 (es)
GR (1) GR851380B (es)
HU (1) HUT37933A (es)
IL (1) IL75427A0 (es)
PL (1) PL253820A1 (es)
PT (1) PT80596B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4568677A (en) * 1983-07-23 1986-02-04 Pfizer Inc. 2-(4-Pyrimidone alkoxyalkyl) dihydropyridine anti-ischaemic and antihypertensive agents
GR851819B (es) * 1984-08-17 1985-11-26 Wyeth John & Brother Ltd
PT100905A (pt) * 1991-09-30 1994-02-28 Eisai Co Ltd Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
US6976162B1 (en) * 2000-06-28 2005-12-13 Intel Corporation Platform and method for establishing provable identities while maintaining privacy
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
CN103259027A (zh) 2005-04-28 2013-08-21 普罗透斯数字保健公司 药物信息系统
KR20090071598A (ko) 2006-09-18 2009-07-01 랩터 파마슈티컬 인코포레이티드 수용체 결합 단백질(rap)-접합체 투여에 의한 간 질환의 치료
PT2398500T (pt) 2009-02-20 2019-06-14 2 Bbb Medicines B V Sistema de entrega de medicamentos à base de glutationas
TWI556839B (zh) 2009-05-06 2016-11-11 研究室護膚股份有限公司 包含活性劑-磷酸鈣粒子複合物之皮膚遞送組成物及其使用方法
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK140695C (da) * 1976-05-07 1980-05-12 Synthelabo Analogifremgangsmaade til fremstilling af 2,4-diamino-6,7-dimethoxyquinazolinderivater eller syreadditionssalte heraf
DK159079A (da) * 1978-05-18 1979-11-19 Pfizer Fremgangsmaade til fremstilling af derivater af 4-amino-2-piperidinoquinazolin eller syreadditionssalte deraf
CS228917B2 (en) * 1981-03-14 1984-05-14 Pfizer Method of preparing substituted derivatives of 1,4-dihydropyridine
DK161312C (da) * 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
DE3363743D1 (en) * 1982-07-22 1986-07-03 Pfizer Ltd Dihydropyridine anti-ischaemic and antihypertensive agents

Also Published As

Publication number Publication date
ES8704480A1 (es) 1987-04-01
DK253585D0 (da) 1985-06-06
IL75427A0 (en) 1985-10-31
US4647565A (en) 1987-03-03
PT80596B (en) 1987-04-21
JPS6133185A (ja) 1986-02-17
GB8414518D0 (en) 1984-07-11
GR851380B (es) 1985-11-25
KR860000286A (ko) 1986-01-27
EP0168151A1 (en) 1986-01-15
AU4334785A (en) 1985-12-12
FI852221A0 (fi) 1985-06-03
FI852221L (fi) 1985-12-08
DK253585A (da) 1985-12-08
HUT37933A (en) 1986-03-28
PL253820A1 (en) 1986-07-01
AU554571B2 (en) 1986-08-28
PT80596A (en) 1985-07-01

Similar Documents

Publication Publication Date Title
ES539281A0 (es) Un procedimiento para la preparacion de derivados de piperidina.
ES546347A0 (es) Un procedimiento para la preparacion de derivados de piperazina 1,4-disustituidos.
ES544644A0 (es) Un procedimiento para la preparacion de derivados de carboxamidoadenosina.
ES538256A0 (es) Un procedimiento para la preparacion de derivados de 2,2'-iminobisetanol.
ES541200A0 (es) Un procedimiento para la preparacion de un derivado de dibenzoilmetano.
ES542703A0 (es) Un procedimiento para la preparacion de derivados de tiazol,2, 4, disustituidos.
ES540901A0 (es) Un procedimiento para la preparacion de derivados de n,n-pipericinilo disustituidos.
ES546236A0 (es) Un procedimiento para la preparacion de derivados de bencimidasol.
ES542120A0 (es) Un procedimiento para la preparacion de 1,4-dihidropiridinas.
ES540609A0 (es) Un procedimiento para la preparacion de pirazolo piridinas.
ES540610A0 (es) Un procedimiento para la preparacion de pirazolopiridinas.
ES530379A0 (es) Un procedimiento para la preparacion de compuestos de 1, 4-dihidropiridina.
ES550504A0 (es) Un procedimiento para la preparacion de derivados de podofilotoxina.
ES547805A0 (es) Un procedimiento para la preparacion de nuevos derivados de guanina.
ES543517A0 (es) Procedimiento para preparar un derivado de 1,3-oxazolidina-2-ona.
ES550829A0 (es) Un procedimiento para la preparacion de derivados de piperazina 1,4-disustituidos.
ES543997A0 (es) Un procedimiento para la preparacion de derivados de 1,4-dihidropiridina.
ES554659A0 (es) Un procedimiento para la preparacion de derivados de piperazimilo 1,4-di sustituidos.
ES539592A0 (es) Un procedimiento para la preparacion de nuevos derivados de 1,4-dihidropiridina.
ES550874A0 (es) Un procedimiento para la preparacion de 3,4-dihidroxifemetilamino derivados 2-ustituidos.
ES554062A0 (es) Procedimiento para la obtencion de 1,4-dihidropiridinas
ES535966A0 (es) Un procedimiento para la preparacion de nuevos derivados de 4,5-dihidro-2h-piridazin-3-ona.
ES557423A0 (es) Procedimiento para la preparacion de derivados de 1,4-dihidropiridina
ES548244A0 (es) Un procedimiento para la preparacion de derivados de 5-cetomilbemicina.
ES540132A0 (es) Un procedimiento para la preparacion de 1,4-aminoalquilamino-9-h-tioxaten-9-onas.